| Typicality: | 0.247 |
| Saliency: | 0.200 |
| among the advantages | 8 | other |
| over the coming days | 2 | temporal |
| vaccine → become → more available | 5 |
| vaccine → be → more accessible | 5 |
| vaccine → reach → more people | 3 |
| negative | neutral | positive |
| 0.026 | 0.384 | 0.590 |
| Raw frequency | 13 |
| Normalized frequency | 0.200 |
| Modifier score | 0.500 |
| Perplexity | 98.201 |